Magnetic resonance imaging detects intestinal barrier dysfunction in a rat model of acute mesenteric ischemia/reperfusion injury

Investigative Radiology

Volumn 44, Issue 6, 2009, Pages 329-335

  Hsiao, Jong Kai ^a   Huang, Ching Ying ^b   Lu, Yen Zhen ^b   Yang, Chung Yi ^a   Yu, Linda Chia Hui ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Gadodiamide; Intestinal barrier function; Mesenteric I R; MRI; Permeabilityassay

Indexed keywords

GADODIAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM COLONY; CONTROL GROUP; CONTROLLED STUDY; ENTEROPATHY; HISTOLOGY; INTESTINE LOOP; ISCHEMIA; LAPAROTOMY; MALE; MESENTERIC ARTERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERMEABILITY BARRIER; PRIORITY JOURNAL; RAT; REPERFUSION; REPERFUSION INJURY; SIGNAL NOISE RATIO; WESTERN BLOTTING;

EID: 67651087221     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181a16762     Document Type: Article

References (41)

1. Mallick IH, Yang W, Winslet MC, et al. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci. 2004;49:1359-1377.
2. Yasuhara H. Acute mesenteric ischemia: the challenge of gastroenterology. Surg Today. 2005;35:185-195.
3. Cinel I, Avlan D, Cinel L, et al. Ischemic preconditioning reduces intestinal epithelial apoptosis in rats. Shock. 2003;19:588-592.
4. Aban N, Cinel L, Tamer L, et al. Ischemic preconditioning reduces caspaserelated intestinal apoptosis. Surg Today. 2005;35:228-234.
5. Wu B, Ootani A, Iwakiri R, et al. Ischemic preconditioning attenuates ischemia-reperfusion-induced mucosal apoptosis by inhibiting the mitochondria-dependent pathway in rat small intestine. Am J Physiol Gastrointest Liver Physiol. 2004;286:G580-G587.
6. Berg RD. Bacterial translocation from the gastrointestinal tract. Trends Microbiol. 1995;3:149-154.
7. Yu LCH, Flynn AN, Turner JR, et al. SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: a novel cellular rescue mechanism? FASEB J. 2005;19:1822-1835.
8. Nazli A, Yang PC, Jury J, et al. Epithelia under metabolic stress perceive commensal bacteria as a threat. Am J Pathol. 2004;164:947-957.
9. Balzan S, de Almeidaq Uadros C, de Cleva R, et al. Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol. 2007;22:464-471.
10. Leaphart CL, Tepas JJ. The gut is a motor of organ system dysfunction. Surgery. 2007;141:563-569.
11. Medeiros AC, Chacon DA, Sales VS, et al. Glucan and glutamine reduce bacterial translocation in rats subjected to intestinal ischemia-reperfusion. J Invest Surg. 2006;19:39-46.
12. Aksoyek S, Cinel I, Avlan D, et al. Intestinal ischemic preconditioning protects the intestine and reduces bacterial translocation. Shock. 2002;18: 476-780.
13. Yu LCH, Montagnac G, Yang PC, et al. Intestinal epithelial CD23 mediates enhanced antigen transport allergy: evidence for novel splice forms. Am J Physiol Gastrointest Liver Physiol. 2003;285:223-234.
14. Feighery LM, Cochrane SW, Quinn T, et al. Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro. Pharm Res. 2007;25:1377-1386.
15. Scott KG, Meddings JB, Kirk DR, et al. Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion. Gastroenterology. 2002;123:1179-1190.
16. Meddings JB, Gibbons I. Discrimination of site-specific alternations in gastrointestinal permeability in the rat. Gastroenterology. 1998;14:83-92.
17. Soderholm JD, Olaison G, Lindberg E, et al. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease-an inherited defect in mucosal defence? Gut. 1999;44:96-100.
18. Tilak GS, Hsu LY, Hoyt RF, et al. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction. Invest Radiol. 2008;43:7-15.
19. Tsuda N, Okada M, Murakami T. Potential of gadolinium- ethoxybenzyldiethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging. Invest Radiol. 2007;42:242-247.
20. Reith W, Forsting M, Vogler H, et al. Early MR detection of experimentally induced cerebral ischemia using magnetic susceptibility contrast agents: comparison between gadopentetate dimeglumine and iron oxide particles. AJNR Am J Neuroradiol. 1995;16:53-60.
21. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. MR enteroclysis: technical considerations and clinical applications. Eur Radiol. 2002;12:2651-2658.
22. Courtsoyiannis NC, Grammatikakis J, Papamastorakis G, et al. Imaging of small intestinal Crohn's disease: comparison between MR enteroclysis and conventional enteroclysis. Eur Radiol. 2006;16:1915-1925.
23. Herrmann KA, Zech CJ, Michaely HJ, et al. Comprehensive magnetic resonance imaging of the small and large bowel using intraluminal dual contrast technique with iron oxide solution and water in magnetic resonance enteroclysis. Invest Radiol. 2005;40:621-629.
24. Saar B, Gschossmann JM, Bonel HM, et al. Evaluation of magnetic resonance colonography at 3.0 Tesla regarding diagnostic accuracy and image quality. Invest Radiol. 2008;43:580-586.
25. Frokjaer JB, Larsen E, Steffensen E, et al. Magnetic resonance imaging of the small bowel in Crohn's disease. Scand J Gastroenterol. 2005;40:832-842.
26. Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging. 2000;25:219-228.
27. Rieber A, Aschoff A, Nussle K, et al. MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol. 2000;10:1377-1382.
28. Schreyer AG, Golder S, Scheibl K, et al. Dark lumen magnetic resonance enteroclysis in combination with MRI colonography for whole bowel assessment in patients with Crohn's disease: first clinical experience. Inflamm Bowel Dis. 2005;11:388-394.
29. Schreyer AG, Herfarth H, Kikinis R, et al. 3D modeling and virtual endoscopy of the small bowel based on magnetic resonance imaging in patients with inflammatory bowel disease. Invest Radiol. 2002;37:528-533.
30. Frericks B, Frank W, Loddenkemper C, et al. Magnetic resonance imaging of experimental inflammatory bowel disease: quantitative and qualitative analyses with histopathologic correlation in a rat model using the ultrasmall iron oxide SHU 555C. Invest Radiol. 2009;44:23-30.
31. Nazli A, Wang A, Steen O, et al. Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia. Infect Immun. 2006;74:192-201.
32. Gurleyik G, Ozturk E, Adaleti R, et al. Effects of prostaglandin E1 and E2 analogues on mucosal injury-induced, and on bacterial translocation promoted by, experimental intestinal obstruction. J Invest Surg. 2004;17:127-134.
33. White JS, Hoper M, Parks RW, et al. Patterns of bacterial translocation in experimental biliary obstruction. J Surg Res. 2006;132:80-84.
34. Caradonna L, Amati L, Magrone T, et al. Enteric bacteria, lipopolysaccharides, and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res. 2000;6:205-214.
35. Madsen KL, Malfair D, Gray D, et al. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis. 1999;5:262-270.
36. Yu LC, Huang CY, Kuo WT, et al. SGLT-1-mediated glucose uptake protects human intestinal epithelial cells against Giardia duodenalis-induced apoptosis. Int J Parasitol. 2008;38:923-934.
37. Rupani B, Caputo FJ, Watkins AC, et al. Relationship between disruption of the unstirred mucus layer and intestinal restitution in loss of gut barrier function after trauma hemorrhagic shock. Surgery. 2007;141:481-489.
38. Moriez R, Salvador-Cartier C, Theodorou V, et al. Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats. Am J Pathol. 2005;167:1071-1079.
39. Kozar RA, Schultz SG, Bick RJ, et al. Enteral glutamine but not alanine maintains small bowel barrier function after ischemia/reperfusion injury in rats. Shock. 2004;21:433-437.
40. Kozar RA, Verner-Cole E, Schultz SG, et al. The immune-enhancing enteral agents arginine and glutamine differentially modulate gut barrier function following mesenteric ischemia/reperfusion. J Trauma. 2004;57:1150-1156.
41. Montalbano JM, Lee FT Jr, Grist TM, et al. Magnetic resonance imaging detection of extraluminal enterally administered gadopentetate dimeglumine in a rat model of intestinal ischemia. Acad Radiol. 1996;3:486-492.